# Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

> **NCT00129220** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 224 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** haloperidol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00129220
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2010-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129220, "Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00129220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*